AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) STIMULATES NORMAL AND MALIGNANT ANGIOGENESIS
Authors: HEITS F WIEDEMANN GJ JELKMANN W
Citation: F. Heits et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) STIMULATES NORMAL AND MALIGNANT ANGIOGENESIS, Deutsche Medizinische Wochenschrift, 123(9), 1998, pp. 259-265
SERUM ERYTHROPOIETIN AND CREATININE CONCENTRATIONS AS PREDICTIVE FACTORS FOR RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN ANEMIC TUMOR PATIENTS ON CHEMOTHERAPY
Authors: FJORNES T WIEDEMANN GJ SACK K JELKMANN W
Citation: T. Fjornes et al., SERUM ERYTHROPOIETIN AND CREATININE CONCENTRATIONS AS PREDICTIVE FACTORS FOR RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN ANEMIC TUMOR PATIENTS ON CHEMOTHERAPY, Oncology Reports, 5(1), 1998, pp. 81-86
TREATMENT OF UNRESECTABLE CARCINOMA OF THE ESOPHAGUS OR THE GASTROESOPHAGEAL JUNCTION BY MESH STENTS WITH OR WITHOUT RADIOCHEMOTHERAPY
Authors: LUDWIG D DEHNE A BURMESTER E WIEDEMANN GJ STANGE EF
Citation: D. Ludwig et al., TREATMENT OF UNRESECTABLE CARCINOMA OF THE ESOPHAGUS OR THE GASTROESOPHAGEAL JUNCTION BY MESH STENTS WITH OR WITHOUT RADIOCHEMOTHERAPY, International journal of oncology, 13(3), 1998, pp. 583-588
FAMILIAL COEXISTENCE OF PRIMARY ANTIPHOSPHOLIPID SYNDROME AND FACTOR-V-LEIDEN
Authors: SCHUTT M KLUTER H HAGEDORNGREIWE M FEHM HL WIEDEMANN GJ
Citation: M. Schutt et al., FAMILIAL COEXISTENCE OF PRIMARY ANTIPHOSPHOLIPID SYNDROME AND FACTOR-V-LEIDEN, Lupus, 7(3), 1998, pp. 176-182
ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE) CHEMOTHERAPY AND SYSTEMIC HYPERTHERMIA
Authors: WIEDEMANN GJ ROBINS HI
Citation: Gj. Wiedemann et Hi. Robins, ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE) CHEMOTHERAPY AND SYSTEMIC HYPERTHERMIA, Onkologie, 21, 1998, pp. 10-11
WHOLE-BODY HYPERTHERMIA COMBINED WITH IFOSFAMIDE AND CARBOPLATIN CAUSES HYPOTENSION AND NEPHROTOXICITY
Authors: BRAUER LP PRIESHOF B WIEDEMANN GJ WEISS C KRIZ W SCHRAMM U ROBINS HI PAGEL H
Citation: Lp. Brauer et al., WHOLE-BODY HYPERTHERMIA COMBINED WITH IFOSFAMIDE AND CARBOPLATIN CAUSES HYPOTENSION AND NEPHROTOXICITY, Journal of cancer research and clinical oncology, 124(10), 1998, pp. 549-554
LOCAL HYPERTHERMIA, HYPERFRACTIONATED RADIATION, AND CISPLATIN IN PREIRRADIATED RECURRENT LYMPH-NODE METASTASES OF RECURRENT HEAD AND NECK-CANCER
Authors: FEYERABEND T STEEVES R JAGER B WIEDEMANN GJ SOMMER K RICHTER E KATSCHINSKI DM ROBINS HI
Citation: T. Feyerabend et al., LOCAL HYPERTHERMIA, HYPERFRACTIONATED RADIATION, AND CISPLATIN IN PREIRRADIATED RECURRENT LYMPH-NODE METASTASES OF RECURRENT HEAD AND NECK-CANCER, International journal of oncology, 10(3), 1997, pp. 591-595
SERUM VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF), A PROGNOSTIC INDICATOR IN SARCOMA AND CARCINOMA PATIENTS
Authors: HEITS F KATSCHINSKI DM WIEDEMANN GJ WEISS C JELKMANN W
Citation: F. Heits et al., SERUM VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF), A PROGNOSTIC INDICATOR IN SARCOMA AND CARCINOMA PATIENTS, International journal of oncology, 10(2), 1997, pp. 333-337
SERUM IMMUNOREACTIVE THROMBOPOIETIN LEVELS IN PATIENTS AND RESPONSE TO ICE-CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Authors: HEITS F WILMSEN U WIEDEMANN GJ JELKMANN W
Citation: F. Heits et al., SERUM IMMUNOREACTIVE THROMBOPOIETIN LEVELS IN PATIENTS AND RESPONSE TO ICE-CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, European journal of cancer, 33, 1997, pp. 66-66
SERUM THROMBOPOIETIN AND INTERLEUKIN-6 CONCENTRATIONS IN TUMOR PATIENTS AND RESPONSE TO CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Authors: HEITS F KATSCHINSKI DM WILMSEN U WIEDEMANN GJ JELKMANN W
Citation: F. Heits et al., SERUM THROMBOPOIETIN AND INTERLEUKIN-6 CONCENTRATIONS IN TUMOR PATIENTS AND RESPONSE TO CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, European journal of haematology, 59(1), 1997, pp. 53-58
QUALITY IN-HOSPITAL TREATMENT - HOW IS IT ASSURED AND WHO PROVIDES THE GUIDELINES
Authors: BURK CG WIEDEMANN GJ KRAUS M BRUCH HP FEHM HL
Citation: Cg. Burk et al., QUALITY IN-HOSPITAL TREATMENT - HOW IS IT ASSURED AND WHO PROVIDES THE GUIDELINES, Medizinische Klinik, 92(5), 1997, pp. 300-303
IN-VITRO STUDIES OF THE HYPERTHERMIC ENHANCEMENT OF ACTIVATED IFOSFAMIDE (4-HYDROPEROXY-IFOSFAMIDE) AND GLUCOSE ISOPHOSPHORAMIDE MUSTARD
Authors: KUTZ ME MULKERIN DL WIEDEMANN GJ KATSCHINSKI DM ROBINS HI
Citation: Me. Kutz et al., IN-VITRO STUDIES OF THE HYPERTHERMIC ENHANCEMENT OF ACTIVATED IFOSFAMIDE (4-HYDROPEROXY-IFOSFAMIDE) AND GLUCOSE ISOPHOSPHORAMIDE MUSTARD, Cancer chemotherapy and pharmacology, 40(2), 1997, pp. 167-171
OPTIMIZATION OF CHEMOTHERAPY ADMINISTRATION FOR CLINICAL 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA
Authors: KATSCHINSKI DM WIEDEMANN GJ MENTZEL M MULKERIN DL TOUHIDI R ROBINS HI
Citation: Dm. Katschinski et al., OPTIMIZATION OF CHEMOTHERAPY ADMINISTRATION FOR CLINICAL 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA, Cancer letters, 115(2), 1997, pp. 195-199
DYNAMIC CHANGES IN SERUM ERYTHROPOIETIN LEVELS IN SOLID TUMOR PATIENTS UNDERGOING 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA AND OR CHEMOTHERAPY/
Authors: KATSCHINSKI DM JELKMANN W WIEDEMANN GJ MENTZEL M MULKERIN DL TOUHIDI R ROBINS HI
Citation: Dm. Katschinski et al., DYNAMIC CHANGES IN SERUM ERYTHROPOIETIN LEVELS IN SOLID TUMOR PATIENTS UNDERGOING 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA AND OR CHEMOTHERAPY/, International journal of hyperthermia, 13(6), 1997, pp. 563-569
INFLUENCE OF CIRCADIAN-RHYTHM ON 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA INDUCTION OF HEMATOPOIETIC GROWTH-FACTORS
Authors: KATSCHINSKI DM WIEDEMANN GJ MENTZEL M MULKERIN DL TOUHIDI R ROBINS HI
Citation: Dm. Katschinski et al., INFLUENCE OF CIRCADIAN-RHYTHM ON 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA INDUCTION OF HEMATOPOIETIC GROWTH-FACTORS, International journal of hyperthermia, 13(6), 1997, pp. 571-576
LACK OF EVIDENCE FOR WHOLE-BODY HYPERTHERMIA-INDUCED CHANGES IN MHC AND NON-MHC IMMUNOLOGICAL FUNCTION VIA CYTOKINE INDUCTION
Authors: ROBINS HI KATSCHINSKI DM DOLEIRE F MULKERIN D WIEDEMANN GJ
Citation: Hi. Robins et al., LACK OF EVIDENCE FOR WHOLE-BODY HYPERTHERMIA-INDUCED CHANGES IN MHC AND NON-MHC IMMUNOLOGICAL FUNCTION VIA CYTOKINE INDUCTION, International journal of hyperthermia, 13(5), 1997, pp. 560-562
INTRACORPOREAL WHOLE-BODY HYPERTHERMIA - TOXICITY ASSESSMENT
Authors: WIEDEMANN GJ KATSCHINSKI DM MENTZEL M MULKERIN D ROBINS HI
Citation: Gj. Wiedemann et al., INTRACORPOREAL WHOLE-BODY HYPERTHERMIA - TOXICITY ASSESSMENT, International journal of hyperthermia, 13(2), 1997, pp. 249-250
RATIONALE AND CLINICAL STATUS OF LOCAL HYPERTHERMIA, RADIATION, AND CHEMOTHERAPY IN LOCALLY ADVANCED MALIGNANCIES
Authors: FEYERABEND T STEEVES R WIEDEMANN GJ RICHTER E ROBINS HI
Citation: T. Feyerabend et al., RATIONALE AND CLINICAL STATUS OF LOCAL HYPERTHERMIA, RADIATION, AND CHEMOTHERAPY IN LOCALLY ADVANCED MALIGNANCIES, Anticancer research, 17(4B), 1997, pp. 2895-2897
SYSTEMIC HYPERTHERMIA AND ICE CHEMOTHERAPY FOR SARCOMA PATIENTS - RATIONALE AND CLINICAL STATUS
Authors: WIEDEMANN GJ ROBINS HI KATSCHINSKI DM MENTZEL M DOLEIRE F KUTZ M WAGNER T
Citation: Gj. Wiedemann et al., SYSTEMIC HYPERTHERMIA AND ICE CHEMOTHERAPY FOR SARCOMA PATIENTS - RATIONALE AND CLINICAL STATUS, Anticancer research, 17(4B), 1997, pp. 2899-2902
INFLUENCE OF INDUCTION OF HSP70 ON THE CYTOTOXICITY OF OXAZAPHOSPHORINE COMPOUNDS AND CISPLATIN
Authors: WOSSMANN W SIEMENS HJ BECK B JANSEN B WIEDEMANN GJ WAGNER T
Citation: W. Wossmann et al., INFLUENCE OF INDUCTION OF HSP70 ON THE CYTOTOXICITY OF OXAZAPHOSPHORINE COMPOUNDS AND CISPLATIN, International journal of oncology, 9(2), 1996, pp. 305-312
IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) COMBINED WITH 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN PATIENTS WITH REFRACTORY SARCOMA
Authors: WIEDEMANN GJ ROBINS HI GUTSCHE S MENTZEL M DEEKEN M KATSCHINSKI DM ELEFTHERIADIS S CRAHE R WEISS C STORER B WAGNER T
Citation: Gj. Wiedemann et al., IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) COMBINED WITH 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN PATIENTS WITH REFRACTORY SARCOMA, European journal of cancer, 32A(5), 1996, pp. 888-892
IFOSFAMIDE (IFO), CARBOPLATIN (CBDCA) AND ETOPOSIDE (VP-16) COMBINED WITH AQUATHERM INDUCED 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA (WBH) FOR REFRACTORY SARCOMA
Authors: WIEDEMANN GJ KATSCHINSKI DM MENTZEL M WAGNER T TOUHIDI R DOLEIRE F ROBINS HI
Citation: Gj. Wiedemann et al., IFOSFAMIDE (IFO), CARBOPLATIN (CBDCA) AND ETOPOSIDE (VP-16) COMBINED WITH AQUATHERM INDUCED 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA (WBH) FOR REFRACTORY SARCOMA, Journal of clinical oncology, 14(5), 1996, pp. 2025-2025
CLINICAL-TRIALS ON THE COMBINATION OF IFO SFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) WITH WHOLE-BODY HYPERTHERMIA
Authors: WIEDEMANN GJ ROBINS HI KATSCHINSKI DM MENTZEL M VANHEEK R TOUHIDI RR BUCSKY P GILLIS W FEYERABEND T DOLEIRE F FREUND C ELEFTHERIADIS S WEISS C WAGNER T
Citation: Gj. Wiedemann et al., CLINICAL-TRIALS ON THE COMBINATION OF IFO SFAMIDE, CARBOPLATIN AND ETOPOSIDE (ICE) WITH WHOLE-BODY HYPERTHERMIA, Medizinische Klinik, 91(5), 1996, pp. 279-283
LOCAL HYPERTHERMIA, RADIATION, AND CHEMOTHERAPY IN LOCALLY ADVANCED MALIGNANCIES
Authors: FEYERABEND T STEEVES R WIEDEMANN GJ WEISS C WAGNER T RICHTER E ROBINS HI
Citation: T. Feyerabend et al., LOCAL HYPERTHERMIA, RADIATION, AND CHEMOTHERAPY IN LOCALLY ADVANCED MALIGNANCIES, Oncology, 53(3), 1996, pp. 214-220
HORMONAL TREATMENT OF ADVANCED BREAST-CAN CER
Authors: GEISLER J WIEDEMANN GJ LONNING PE
Citation: J. Geisler et al., HORMONAL TREATMENT OF ADVANCED BREAST-CAN CER, Deutsche Medizinische Wochenschrift, 120(8), 1995, pp. 263-267
Risultati: 1-25 | 26-31